Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections.
作者信息
Karaba Andrew H, Johnston Trevor S, Aytenfisu Tihitina Y, Woldemeskel Bezawit A, Garliss Caroline C, Cox Andrea L, Blankson Joel N
机构信息
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
出版信息
Lancet Microbe. 2022 Sep;3(9):e644. doi: 10.1016/S2666-5247(22)00180-X. Epub 2022 Jun 22.
Abstract
摘要
相似文献
1
Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections.在发生突破性感染的加强免疫个体中，奥密克戎BA.2亚谱系的中和作用较低。
Lancet Microbe. 2022 Sep;3(9):e644. doi: 10.1016/S2666-5247(22)00180-X. Epub 2022 Jun 22.
2
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.奥密克戎亚变体的中和敏感性、融合性和感染性。
Genome Med. 2022 Dec 29;14(1):146. doi: 10.1186/s13073-022-01151-6.
3
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
4
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages.奥密克戎 BA.1 突破性感染灭活 COVID-19 疫苗接种者诱导了针对不同奥密克戎亚谱系的抗体和 T 细胞反应的不同模式。
Emerg Microbes Infect. 2023 Dec;12(1):2202263. doi: 10.1080/22221751.2023.2202263.
5
In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.基于全基因组测序的奥密克戎变异株 BA.4 和 BA.5 对 SARS-CoV-2 检测 RT-qPCR 检测方法敏感性影响的计算机评估。
J Med Virol. 2023 Jan;95(1):e28241. doi: 10.1002/jmv.28241. Epub 2022 Nov 8.
6
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.SARS-CoV-2 奥密克戎 BA.5：与关注的病毒变体相比，其对潜在体液反应的趋化性和逃逸能力以及对临床免疫疗法的耐药性不断进化。
EBioMedicine. 2022 Oct;84:104270. doi: 10.1016/j.ebiom.2022.104270. Epub 2022 Sep 18.
7
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong.三剂疫苗接种诱导的免疫反应可预防新冠病毒奥密克戎BA.2：香港一项基于人群的研究
Lancet Reg Health West Pac. 2023 Mar;32:100660. doi: 10.1016/j.lanwpc.2022.100660. Epub 2022 Dec 23.
8
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2.奥密克戎 BA.1 中和抗体反应在德尔塔突破性感染后与 BNT162b2 加强针接种相比。
BMC Infect Dis. 2023 May 4;23(1):282. doi: 10.1186/s12879-023-08272-2.
9
Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections.奥密克戎 BA.5 对先前感染奥密克戎 BA.1/BA.2 后接种疫苗人群的中和作用。
Emerg Infect Dis. 2022 Dec;28(12):2575-2577. doi: 10.3201/eid2812.221304. Epub 2022 Nov 8.
10
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.在接受一剂BNT162b2疫苗加强针后，老年疗养院居民对新冠病毒奥密克戎变异株的中和抗体反应：一项基于社区的前瞻性纵向队列研究。
EClinicalMedicine. 2022 Jul 22;51:101576. doi: 10.1016/j.eclinm.2022.101576. eCollection 2022 Sep.
引用本文的文献
1
Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection.奥密克戎BA.2.2突破性感染和奥密克戎BA.5再次感染后的体液免疫和细胞免疫反应。
iScience. 2024 Jun 15;27(7):110283. doi: 10.1016/j.isci.2024.110283. eCollection 2024 Jul 19.
2
The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions.新冠疫情对炎症性肠病患者的影响：经验教训与未来方向
J Clin Med. 2022 Nov 27;11(23):7002. doi: 10.3390/jcm11237002.
本文引用的文献
1
SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.奥密克戎变异株流行期间突破性感染的加强疫苗接种者中的 SARS-CoV-2 特异性免疫应答。
JCI Insight. 2022 May 23;7(10):e159474. doi: 10.1172/jci.insight.159474.
2
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
3
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.第三剂 SARS-CoV-2 疫苗可提高实体器官移植受者对关注变异株的中和抗体。
Am J Transplant. 2022 Apr;22(4):1253-1260. doi: 10.1111/ajt.16933. Epub 2022 Jan 18.
Zotero 插件